luspatercept,epoetin alfa
bms
['commands', 'lusp', 'commands trial', 'commands,(-recommands)', 'mds']
 presenting commands trial evaluating luspatercept vs epo in tx naive low risk mds demonstrating a benefit- curious on whether this will lead to regulatory approval and will the benefit be worth cost in subgroups with more modest benefit (non-rs) #asco23 #mdssm 
Associate clinical professor at UC Irvine focused on CLL/SLL and CHIP/CCUS/MDS. Animal and nature lover. Tweets are my own.